References
- Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001; 32:794-800; PMID:11229848; http://dx.doi.org/10.1086/319218
- Siemieniuk RA, Gregson DB, Gill MJ. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study. BMC Infect Dis 2011; 11:314; PMID:22078162; http://dx.doi.org/10.1186/1471-2334-11-314
- Yin Z, Rice BD, Waight P, Miller E, George R, Brown AE, Smith RD, Slack M, Delpech VC. Invasive pneumococcal disease among HIV-positive individuals, 2000–2009. AIDS 2012; 26:87-94; PMID:22008657; http://dx.doi.org/10.1097/QAD.0b013e32834dcf27
- Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberger M, Miron D, Temper V, et al. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine 2015; 33:1135-42; PMID:25613717; http://dx.doi.org/10.1016/j.vaccine.2015.01.030
- Mor Z, Weinstein R, Grotto I, Levin Y, Chemtob D. Thirty years of HIV in Israel: current epidemiology and future challenges. BMJ Open 2013; 3(7); PMID:23833144; http://dx.doi.org/10.1136/bmjopen-2013-003078
- Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Linares J, Gudiol F. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165:1533-40; PMID:16009870; http://dx.doi.org/10.1001/archinte.165.13.1533
- Campo RE, Campo CE, Peter G, Zuleta J, Wahlay NA, Cleary T, Kolber MA, Dickinson GM. Differences in presentation and outcome of invasive pneumococcal disease among patients with and without HIV infection in the pre-HAART era. AIDS Patient Care STDs 2005; 19:141-9; PMID:15798381; http://dx.doi.org/10.1089/apc.2005.19.141
- Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132:182-90; PMID:10651598; http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00003
- Grau I, Ardanuy C, Linares J, Podzamczer D, Schulze MH, Pallares R. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease. HIV Med 2009; 10:488-95; PMID:19459987; http://dx.doi.org/10.1111/j.1468-1293.2009.00717.x
- Jordano Q, Falco V, Almirante B, Planes AM, del Valle O, Ribera E, Len O, Pigrau C, Pahissa A. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:1623-8; PMID:15156452; http://dx.doi.org/10.1086/420933
- Cohen C, Naidoo N, Meiring S, de Gouveia L, von Mollendorf C, Walaza S, Naicker P, Madhi SA, Feldman C, Klugman KP, et al. Streptococcus pneumoniae serotypes and mortality in adults and adolescents in South Africa: Analysis of national surveillance data, 2003 – 2008. PloS One 2015; 10:e0140185; PMID:26460800; http://dx.doi.org/10.1371/journal.pone.0140185